[Skip to content]

Self Help UK


Having Fun After Cancer
Organisation name
Cancer patients are living longer, but British patients are still near bottom of European survival tables (17th).

One reason is side effects of hormonal drugs causing problems during the five years of follow-up treatment, which the NHS tends to let charities handle. Europeans are given advice by their health services.

The NHS says medicine 'must be free at the point of delivery', yet Macmillan says the average cancer patient spends over £2,000 on extras - sometimes on products that are not proven, when they could buy those that have had clinical trials in US, France etc..if NHS staff were allowed to mention these.

www.after-cancer.com gives information about these products, and treatments that have been proven to help. That have had

a) clinical trials in Europe, USA, etc.

b) and/or are available on NHS - but not generally known

c) available from agencies such as Macmillan, Cancer Resource Centre, etc. without having to go abroad.

d) or have been tested by US, Australian and European Food and Drug Agencies

As an investigative journalist, when Verite got cancer she went to Europe to find out why they survive longer - and has details of products that we can buy to help handle side effects of drugs.

NHS believes that treatment 'must be free at point of delivery', so patients come off 5-year post cancer drug cycle because they are not told of products that can help. Europeans are - hence their survival rates are better.

But there is no reason why Britons can't buy helpful, clinically-trialled products for themselves, especially if this means they can counter side effects of the five-year drug cycle - and stay on these life-saving drugs.
Street address
54a, Ifield Road
SW10 9AD
Main Phone No
020 7351 4434
Main Contact: Name
Verite Reily Collins
Main Contact: Job Title
Medical Journalist
Is this a national or local organisation?
Is there a local support network?
Does the organisation provide free publications or leaflets?
Does the organisation publish a newsletter?
Does the organisation fund research?